[Potential of azoximere bromide for treatment of patients with acute inflammatory and infectious upper respiratory diseases].

Valerij M Svistushkin G N Nikiforova Kseniya Eremeeva A S Dekhanov P A Kochetkov

Published in: Terapevticheskii arkhiv (2023)

Treatment with Polyoxidonium® contributes to achieving favorable outcomes in patients with inflammatory and infectious upper respiratory diseases. The study drug has a high safety profile.

Keyphrases

oxidative stress
metabolic syndrome
risk assessment
drug induced
smoking cessation